跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12 条关于
“Yutrepia”
全部
12
临床试验
0
药物
0
机构
0
资讯
12
去年
Liquidia Secures $100M Financing to Advance Yutrepia for Pulmonary Hypertension Treatment
去年
Court Dismisses United Therapeutics' Challenge Against Liquidia's YUTREPIA, Clearing Path for May Launch
去年
Liquidia Secures $50 Million Funding Following YUTREPIA Commercial Launch and Legal Victory
8个月前
Liquidia Reports Strong YUTREPIA Launch with $148.3M in Full-Year 2025 Sales, Expands Clinical Pipeline
去年
Liquidia's YUTREPIA Achieves Rapid Market Uptake with 900+ Prescriptions in 11 Weeks Post-Approval
2年前
Liquidia's Yutrepia Receives Tentative FDA Approval for Pulmonary Hypertension
去年
Supreme Court Declines to Review United Therapeutics' Patent, Clearing Path for YUTREPIA
10个月前
Liquidia's YUTREPIA Achieves Commercial Success with $51.7M Q3 Sales, Attracting Major Biotech Fund Investment
上个月
Liquidia's YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud's Phenomenon
8个月前
Liquidia Loses Bid to Dismiss United Therapeutics Patent Lawsuit Over Yutrepia Lung Drug
第 1 页,共 2 页
上一页
下一页